Researchers link vitamin B12 to ALS treatment

Tuesday, May 13, 2003 at 06:45 JST
TOKUSHIMA — A group of University of Tokushima researchers has discovered that methylcobalamin, a type of vitamin B12, could slow down the attack of amyotrophic lateral sclerosis (ALS), a progressive neuro-degenerative illness also known as Lou Gehrig's disease.

Researchers say methylcobalamin treatment could prolong the life of severe ALS patients. The research group, led by Ryuji Kaji, professor of neurology at the University of Tokushima, plans to present the results at a meeting of the Japanese Society of Neurology in Yokohama on Thursday. (Kyodo News)

Copying or using text, photographs,
illustrations, video or images
appearing on this site without
permission is prohibited.

All rights reserved.
Copyright ©2000 - 2003

Editorial comments: jteditor@japantoday.com

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.